Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions
Open Access
- 1 January 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (1), e4112
- https://doi.org/10.1371/journal.pone.0004112
Abstract
S1PL is an aldehyde-lyase that irreversibly cleaves sphingosine 1-phosphate (S1P) in the terminal step of sphingolipid catabolism. Because S1P modulates a wide range of physiological processes, its concentration must be tightly regulated within both intracellular and extracellular environments. In order to better understand the function of S1PL in this regulatory pathway, we assessed the in vivo effects of different levels of S1PL activity using knockout (KO) and humanized mouse models. Our analysis showed that all S1PL-deficient genetic models in this study displayed lymphopenia, with sequestration of mature T cells in the thymus and lymph nodes. In addition to the lymphoid phenotypes, S1PL KO mice (S1PL−/−) also developed myeloid cell hyperplasia and significant lesions in the lung, heart, urinary tract, and bone, and had a markedly reduced life span. The humanized knock-in mice harboring one allele (S1PLH/−) or two alleles (S1PLH/H) of human S1PL expressed less than 10 and 20% of normal S1PL activity, respectively. This partial restoration of S1PL activity was sufficient to fully protect both humanized mouse lines from the lethal non-lymphoid lesions that developed in S1PL−/− mice, but failed to restore normal T-cell development and trafficking. Detailed analysis of T-cell compartments indicated that complete absence of S1PL affected both maturation/development and egress of mature T cells from the thymus, whereas low level S1PL activity affected T-cell egress more than differentiation. These findings demonstrate that lymphocyte trafficking is particularly sensitive to variations in S1PL activity and suggest that there is a window in which partial inhibition of S1PL could produce therapeutic levels of immunosuppression without causing clinically significant S1P-related lesions in non-lymphoid target organs.Keywords
This publication has 64 references indexed in Scilit:
- S1P1 Receptor Signaling Overrides Retention Mediated by Gαi-Coupled Receptors to Promote T Cell EgressImmunity, 2008
- Distinctive T Cell-suppressive Signals from Nuclearized Type 1 Sphingosine 1-Phosphate G Protein-coupled ReceptorsOnline Journal of Public Health Informatics, 2007
- Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast–osteoblast couplingThe EMBO Journal, 2006
- Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancerProceedings of the National Academy of Sciences of the United States of America, 2006
- Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropismThe Journal of Experimental Medicine, 2006
- Evidence that FTY720 induces rat thymocyte apoptosisTransplant Immunology, 2006
- CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organsNature, 2006
- CHEMOKINES, SPHINGOSINE-1-PHOSPHATE, AND CELL MIGRATION IN SECONDARY LYMPHOID ORGANSAnnual Review of Immunology, 2005
- Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zoneNature Immunology, 2004
- Sphingosine 1-phosphate signalling in mammalian cellsBiochemical Journal, 2000